Cargando…
EFSPI/PSI working group on data sharing: accessing and working with pharmaceutical clinical trial patient level datasets – a primer for academic researchers
BACKGROUND: Access to patient level datasets from clinical trial sponsors continues to be an important topic for the Pharmaceutical Industry as well as academic institutions and researchers. How to make access to patient level data actually happen raises many questions from the perspective of the re...
Autores principales: | Sudlow, Rebecca, Branson, Janice, Friede, Tim, Morgan, David, Whately-Smith, Caroline |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4943504/ https://www.ncbi.nlm.nih.gov/pubmed/27410386 http://dx.doi.org/10.1186/s12874-016-0171-x |
Ejemplares similares
-
Commentary on: Subgroup analysis and interpretation for phase 3 confirmatory trials: White Paper of the EFSPI/PSI working group on subgroup analysis by Dane, Spencer, Rosenkranz, Lipkovich, and Parke
por: Hemmings, Robert, et al.
Publicado: (2019) -
Sharing quality and safety improvement work in the field of mental health
por: Shah, Amar
Publicado: (2018) -
PSI: The Dutch Academic Infrastructure for shared biobanks for translational research
por: Talmon, Jan L., et al.
Publicado: (2008) -
Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers
por: Adamski, Jakub, et al.
Publicado: (2010) -
Data sharing from pharmaceutical industry sponsored clinical studies: audit of data availability
por: Hopkins, Ashley M., et al.
Publicado: (2018)